---
schema_version: "secwatch.filing_event.v1"
accession: "0001376339-26-000032"
form_type: "8-K"
ticker: "MDXG"
cik: "0001376339"
company_name: "MIMEDX GROUP, INC."
filed_at: "2026-04-29T23:59:59+00:00"
generated_at: "2026-05-15T01:39:19.023984+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# MiMedx Q1 net sales $59M (-33% YoY), loss $11M; cuts FY guidance to $260-290M

## Summary
- Q1 net sales $59M, down 33% YoY from $88M; net loss $11M vs net income $7M a year ago.
- Surgical product sales up 13% YoY; Wound sales down 60% due to Medicare payment cap per cm².
- Gross margin fell to 71% from 81% on pricing pressure and unfavorable product mix.
- FY2026 net sales guidance lowered to $260-290M; Adjusted EBITDA expected approximately breakeven.
- Company plans $40M annualized cost savings; CEO targets return to profitability in H2 and double-digit growth in 2027.

## SEC filing metadata
- accession: 0001376339-26-000032
- form_type: 8-K
- ticker: MDXG
- cik: 0001376339
- company_name: MIMEDX GROUP, INC.
- filed_at: 2026-04-29T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1376339/000137633926000032/0001376339-26-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1376339/000137633926000032/mdxg-20260429.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001376339-26-000032
- JSON: https://secwatch.observer/filing/0001376339-26-000032.json
- Plain text: https://secwatch.observer/filing/0001376339-26-000032.txt

## Key facts
- Earnings Releases
  MIMEDX GROUP, INC. reported first quarter 2026 results: revenue $59 million, net income $11 million. Guidance lowered.
  - Period: first quarter 2026
  - Revenue: $59 million
  - Net income: $11 million
  - Guidance: lowered
  - Result: reported results
  source text: MIMEDX Announces First Quarter 2026 Operating & Financial Results Reports First Quarter Net Sales of $59 Million Revises 2026 Net Sales and Adjusted EBITDA Expectations
  evidence_url: https://www.sec.gov/Archives/edgar/data/1376339/000137633926000032/0001376339-26-000032-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.